Quantcast

Latest Glenmark Pharmaceuticals Stories

2014-07-17 08:28:49

MUMBAI, July 17, 2014 /PRNewswire/ -- - The Facility Will be Situated in Monroe, North Carolina, USA - It Will Manufacture Oral Solids, Injectables and Topicals Over a Five Year Period Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the US. The company plans to set up this manufacturing facility at Monroe Corporate Center, North Carolina, USA. The facility will be spread...

2014-07-02 12:28:31

MUMBAI, India, July 2, 2014 /PRNewswire/ -- ~All the expectorant pet bottles used in creating this smiley are to be donated to 32 Government Hospitals across the country to provide relief to less-privileged patients during monsoons~ ~Nationwide study conducted by Glenmark in Government Hospitals revealed increasing numbers of patients suffering from cough, cold, influenza and other related illnesses during monsoon~ On July 1st - Doctor's Day - a large smiley...

2014-06-04 08:29:36

MUMBAI and LA CHAUX-DE-FONDS, Switzerland, June 4, 2014 /PRNewswire/ -- - State-of-the-art Manufacturing Facility for Supply of Clinical Trial Material - With the Facility Glenmark has end-to-end Capabilities for the Development of Novel, State-of-the-art Monoclonal Antibodies Including Bi-specific Antibodies Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, India (GPL), announced the opening of its new cGMP...

2014-04-29 08:35:02

MUMBAI, April 29, 2014 /PRNewswire/ -- SOURCE Glenmark Pharmaceuticals

2014-04-03 12:28:34

MUMBAI, India, April 3, 2014 /PRNewswire/ -- - GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1 - The molecule has successfully completed pre-clinical and Phase 1 enabling studies. Regulatory submission has been filed for Phase 1 trial (first-in-human) with MHRA, UK - mPGES-1 inhibitors selectively block the production of PGE2 while sparing other prostanoids of physiological importance...

2014-04-01 08:29:32

WOODCLIFF LAKE, N.J., April 1, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that Terrance J. Coughlin has been named chief operating officer. In this capacity, Mr. Coughlin will be responsible for Par's global manufacturing activities, research and development efforts and will be instrumental in the new product selection process. Mr. Coughlin joins Par from Glenmark Generics, Inc. USA/Glenmark Generics Limited where he most recently served as president...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related